Brief report · 28 Feb 2025
Short communicationPublished 28 Feb 2022
Post Covid-19 patients who develop lung fibrosis have lower plasma levels of ifn but higher levels of il-1 and tgf
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background. SARS-CoV-2 has caused a world-wide pandemic inducing a disease known as coronavirus disease 19 COVID-19, which may be associated to pulmonary fibrosis. A significant number of COVID-19 patients, although negative to the oral-pharyngeal swab, experience prolonged symptoms, herein called post COVID-19 (PC). Aims and objectives. Based on the fact that the mechanism/s underlying SARS-CoV-2- derived pulmonary fibrosis are still not well defined, the aim of this study was to identify blood biomarkers to predict lung fibrosis-like changes in PC patients Methods. We used blood samples collected from healthy subjects, anti-SARS-CoV-2 vaccinated (VAX) subjects, and PC patients who were stratified according to the severity of the disease and chest computed tomography (CT) scan data. Results. We found that C reactive protein (CRP), complement complex C5b-9 and LDH, but not IL-6, were still higher in PC patients, independent of the severity of the disease and lung fibrotic areas. Interestingly, fibrotic PC was characterized by higher plasma levels of IL1α, CXCL-10, TGF-β, but not of IFN-β, compared to healthy and VAX groups. In particular, 19 out of 23 (82.6%) severe PC and 8 out of 29 (27.6%) moderate PC patients presented signs of lung fibrosis, associated to lower levels of IFN-β, but higher IL-1α and TGF-β. Conclusions. Our data suggest that higher IL-1α and TGF-β, and lower plasma levels of IFNβ could predict an increased relative risk (RR = 2.8) of lung fibrosis-like changes in PC patients
Keywords
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Lung.
Commentary · 28 Feb 2025
Immunological Pathways in Pulmonary Tuberculosis: Host-pathogen Interactions
Opinion · 28 Feb 2025
Interstitial Lung Diseases: Clinical Classification and Diagnostic Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Lung
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Chiara Colarusso”
